AS-71: Early Statin Therapy Within 48-Hours Decreased 1-Year Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction

Abstract

HMG-CoA reductase inhibitor (statin) reduces mortality and adverse cardiac events in patients with acute coronary syndrome. We thought early statin therapy would be effective in reducing major adverse cardiac events (MACE) in patients with acute myocardial infarction (AMI).